1 min read

Surgical Infection Society (SIS) 38th Annual Meeting

Veristat will attend the Surgical Infection Society’s (SIS) 38th Annual Meeting taking place from April 22 - 25, 2018 in Westlake Village, CA.  

ErinMathias_Biostatistics CROMeet up with  Erin Mathias MS, MPH, Manager of Biostatistics  at this event as she co-authored a poster presentation that will be presented on  Wednesday, April 25, 2018 from 15:30-17:30 in Ballroom A.


 Mini Abstract for Presentation | ACS-MO10

Title: 

ACS-MO10 Length of therapy during a phase 3 study of eravacycline and meropenem for complicated intra-abdominal infection

Authors: 

Kenneth Lawrence, Tetraphase Pharmacueticals; Erin Mathias, Veristat; Ekaterina Efimova, Tetraphase Pharmaceuticals; John Mohr, Tetraphase Pharmaceuticals; Melanie Olesky, Tetraphase Pharmaceuticals; Patrick Horn, Tetraphase Pharmaceuticals; Philip Barie, Weill Cornell Medicine, New York, NY

Background:

The recent Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial demonstrated that, for patients with complicated intra-abdominal infection (cIAI) after adequate surgical or interventional radiologic source control, short-duration antibiotic therapy (~ 4 d) was associated with similar outcomes compared to longer-duration therapy (~ 8 d). This study was performed to assess prescribing of antibiotic therapy for cIAI subsequent to STOP-IT with respect to duration, and to determine patient- or disease-related characteristics related to shorter treatment courses, regardless of patient severity of illness.

 

Meet Us At SIS or Schedule A Meeting:

Meet up with Erin at the SIS Annual Meeting, she will be on hand at the poster presentation to answer any questions.

To schedule a  meeting at this event or anytime with Veristat, simply fill out the form on the right hand side of the page.

Explore More About Veristat:

Our integrated project teams help you make calculated data-driven decisions throughout each step of your clinical trial.  We ensure that your development program is be rooted in biometrics from beginning to end.   Learn more about our Biometrics offering.

 

Share This Event:

   

4 min read

Plenary Session Presentation: Putting Science First in Rare Disease Studies

Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...

1 min read

Swiss Biotech Day

Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024 

With nearly 30 years of experience in clinical trial...